Range
61.67 - 63.49
Vol / Avg.
287K/391.1K
Div / Yield
-
52 Wk
59.55 - 90.19
Mkt Cap
3.8B
Payout Ratio
-
Open
62.07
P/E
-
EPS
-1.98
Shares
60.7M
Outstanding
60.7M
Total Float
54.3M
Sector: Health Care.Industry: Biotechnology
Arena Pharmaceuticals is a biotechnology company targeting G-protein-coupled receptors. The company has one internally discovered drug, lorcaserin, which has been approved and is marketed in the U.S. and South Korea to target weight management. It is commercialized under the brand name Belviq. The company is collaborating with Eisai to market Belviq in other countries. It has a presence in Europe through its Swiss subsidiary, Arena GmbH. The company's pipeline contains drugs targeting autoimmune diseases, vascular diseases, thrombotic diseases, dementia-associated psychosis, nervous system issues, and pain.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-05
REV
Q1 2021Est.ActualSurprise
EPS-2.160-1.980 0.1800
REV570.000K0-570.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ARNAArena Pharmaceuticals0%3.8B

Arena Pharmaceuticals Frequently Asked Questions

Q

How do I buy Arena Pharmaceuticals (ARNA) stock?

A

You can purchase shares of Arena Pharmaceuticals (NASDAQ: ARNA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Arena Pharmaceuticals's (ARNA) competitors?

Q

What is the target price for Arena Pharmaceuticals (ARNA) stock?

A

The latest price target for Arena Pharmaceuticals (NASDAQ: ARNA) was reported by Goldman Sachs on May 18, 2021. The analyst firm set a price target for 90.00 expecting ARNA to rise to within 12 months (a possible 45.49% upside). 12 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Arena Pharmaceuticals (ARNA)?

A

The stock price for Arena Pharmaceuticals (NASDAQ: ARNA) is $61.86 last updated Today at 8:00:03 PM.

Q

Does Arena Pharmaceuticals (ARNA) pay a dividend?

A

There are no upcoming dividends for Arena Pharmaceuticals.

Q

When is Arena Pharmaceuticals (NASDAQ:ARNA) reporting earnings?

A
Arena Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.
Q

Is Arena Pharmaceuticals (ARNA) going to split?

A

There is no upcoming split for Arena Pharmaceuticals.

Q

What sector and industry does Arena Pharmaceuticals (ARNA) operate in?

A

Arena Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.